254.10
+21.00
+(9.01%)
At close: 8:03:30 AM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 6 |
| Avg. Estimate | 3.44B | 3.71B | 14.15B | 14.89B |
| Low Estimate | 3.28B | 3.53B | 13.42B | 14.44B |
| High Estimate | 3.55B | 3.95B | 15.1B | 15.84B |
| Year Ago Sales | 3.64B | 3.64B | 13.84B | 14.15B |
| Sales Growth (year/est) | -5.59% | 1.80% | 2.27% | 5.24% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RS6.F | -- | -- | -- | -- |
| S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
| Maintains | Keybanc: Overweight to Overweight | 2/24/2025 |
| Maintains | Keybanc: Overweight to Overweight | 1/22/2025 |
| Initiated | Goldman Sachs: Neutral | 12/2/2024 |
| Maintains | BMO Capital: Outperform to Outperform | 10/25/2024 |
| Maintains | Keybanc: Overweight to Overweight | 10/14/2024 |
| Downgrade | Wolfe Research: Peer Perform to Underperform | 7/26/2024 |